Differential IRAK signaling in hematologic malignancies

Experimental Hematology

Volumn 41, Issue 12, 2013, Pages 1005-1007

  Rhyasen, Garrett W ^a,b   Bolanos, Lyndsey ^a,b   Starczynowski, Daniel T ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ENZYME ACTIVITY; HEMATOLOGIC MALIGNANCY; HUMAN; INNATE IMMUNITY; LARGE CELL LYMPHOMA; LETTER; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

HEMATOLOGIC NEOPLASMS; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MYELODYSPLASTIC SYNDROMES; SIGNAL TRANSDUCTION;

EID: 84888876950     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.09.008     Document Type: Letter

References (10)

1. Flannery S., Bowie A.G. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochem Pharmacol 2010, 80:1981-1991.
2. Janssens S., Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell 2003, 11:293-302.
3. Ngo V.N., Young R.M., Schmitz R., Jhavar S., Xiao W., Lim K.H., Kohlhammer H., Xu W., Yang Y., Zhao H., et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011, 470:115-119.
4. Cao Z., Henzel W., Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996, 271:1128-1131.
5. Burns K., Martinon F., Esslinger C., et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998, 273:12203-12209.
6. Davis R.E., Ngo V.N., Lenz G., et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010, 463:88-92.
7. Rhyasen G.W., Bolanos L., Fang J., et al. Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome. Cancer Cell 2013, 24:90-104.
8. Wei Y., Dimicoli S., Bueso-Ramos C., et al. Toll-like receptor alterations in myelodysplastic syndrome. Leukemia 2013, 27:1832-1840.
9. Corey S.J., Minden M.D., Barber D.L., Kantarjian H., Wang J.C., Schimmer A.D. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 2007, 7:118-129.
10. Pellagatti A., Cazzola M., Giagounidis A., et al. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia 2010, 24:756-764.